Profiling of protein-protein interactions via single-molecule techniques predicts the dependence of cancers on

Hong-Won Lee1,2,3,4,5, Byoungsan Choi4, Han Na Kang6

  • 1School of Biological Sciences and Institute for Molecular Biology and Genetics, Seoul National University, Seoul, South Korea.

Insights

Understanding protein interactions in cancer helps tailor therapies. This study reveals how epidermal growth factor receptor (EGFR) mutations alter signaling complexes, aiding prediction of targeted therapy response in cancers lacking specific mutations.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Cancer involves genetic and epigenetic changes altering protein-protein interactions (PPIs).
  • Characterizing signaling complexes is crucial for developing targeted cancer therapies.
  • The human epidermal growth-factor receptor (HER) family plays a key role in various cancers.

Purpose of the Study:

  • To investigate how genetic alterations in cancer cells rewire cellular signaling pathways via PPIs.
  • To characterize signaling complexes of the HER family in specific cancers.
  • To explore the potential of PPI analysis for predicting targeted therapy response.

Main Methods:

  • Utilized single-molecule pull-down and co-immunoprecipitation techniques.
  • Analyzed cancer-specific signaling phenotypes, including post-translational modifications and downstream PPIs.
  • Employed co-immunoprecipitation profiling to screen for EGFR-dependent cancers.

Main Results:

  • Activating mutations in the epidermal growth-factor receptor (EGFR) gene promote large protein complex formation around mutant EGFR.
  • Mutant EGFR signaling showed reduced dependency on phosphotyrosine residues.
  • HER-family PPI strength correlated with cellular dependence on HER-family signaling in breast and lung adenocarcinomas.
  • Identified non-small-cell lung cancers responsive to EGFR-targeted inhibitors using co-immunoprecipitation profiling.

Conclusions:

  • The study demonstrates a method to characterize cancer signaling complexes and predict targeted therapy response.
  • Findings highlight the role of altered PPIs in mutant EGFR signaling and cancer cell dependence.
  • This approach may aid in selecting patients for targeted therapies, especially in cancers without actionable genomic mutations.

Related Concept Videos

G-protein Coupled Receptors01:21

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
131.7K
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
576
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
538
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.5K
Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.6K
Protein and Protein Structure02:15

Protein and Protein Structure

Proteins are one of the most abundant organic molecules in living systems and have the most diverse range of functions of all macromolecules. Proteins may be structural, regulatory, contractile, or protective. They may serve in transport, storage, or membranes; or they may be toxins or enzymes. Their structures, like their functions, vary greatly. They are all, however, amino acid polymers arranged in a linear sequence.
A protein's shape is critical to its function. For example, an enzyme...
87.2K